Oncological diseases are today one of the most dangerous threats to the health and life of a modern person. And, despite the fact that a universal, equally effective means for each patient does not yet exist, new methods and development of diagnostics, as well as treatment, have appeared quite often recently.
In the treatment of cancer, correct and timely diagnosis is important not only during the initial examination, but also at each stage of treatment, to control changes in the activity and properties of cancer cells. Under the influence of chemotherapy, immune therapy, radiotherapy, as well as other powerful therapeutic strategies, cancer cells undergo changes, and it is very important to track them in time to make changes to the treatment program.
One of the new methods for diagnosing cancer has been introduced in Israeli clinics. Paying attention to the fact that the individual characteristics of the body react differently to the development of oncological tumors, Israeli experts have proposed a completely new diagnostic technique, which was called the oncotest, or CAN test.
A key feature of the CAN oncotest in Israel is the reconstruction in a laboratory environment of a medium similar in properties and biological activity to the patient’s body environment. A biopsy sample of the patient’s tissue is placed in this medium. Further, doctors act on this sample with various anti-cancer drugs in order to determine the set of drugs, as well as the procedures that will be most effective for this particular patient, taking into account his individual immune characteristics.
The CAN test determines the sensitivity and activity of cancers and allows you to predict with a high degree of probability the effectiveness of the selected individual treatment strategy. CAN test allows you to pre-avoid less effective procedures that have a depressing effect on the patient’s body as a whole, and achieve recovery, as they say, with little blood.
Currently successfully tested on more than two thousand cancer patients and is becoming the basic standard that is used in the diagnosis of cancer. The results of the oncotest, as a rule, are provided ten days after the biopsy and the provision of a tissue sample of the affected organ of the patient.
The CAN test, along with the methods of molecular oncology in Israel, opens a new stage in the fight of man with cancer. Treatment methods in oncology are becoming more accurate, more manageable and more meaningful. More and more patients are hoping for complete healing and a return to their normal full lives.